Catalyst Pharmaceuticals, Inc. (CPRX)
23.94
+0.06
(+0.25%)
USD |
NASDAQ |
Mar 03, 16:00
23.81
-0.13
(-0.54%)
After-Hours: 18:54
Catalyst Pharmaceuticals Shareholders Equity (Quarterly) : 954.27M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 489.09M |
| Rigel Pharmaceuticals, Inc. | 117.61M |
| United Therapeutics Corp. | 7.096B |
| Karyopharm Therapeutics, Inc. | -292.93M |
| Krystal Biotech, Inc. | 1.220B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.107B |
| Total Liabilities (Quarterly) | 152.54M |
| Debt to Equity Ratio | 0.0029 |
| Current Ratio | 6.076 |
| Net Debt Paydown Yield | 0.00% |